Benufutamab Antibody
Benufutamab (GEN1029) is a DR5-targeting agonistic antibody developed for oncology research. It induces apoptosis in tumor cells and has demonstrated anti-tumor activity in preclinical studies of solid tumors, supporting its investigation in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
Hx-DR5-01, Hx-DR5-05, GEN1029, GEN 1029
Target
Apoptosis, TNF
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
6.2 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.1 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP315130 20 µg
Adenylate Kinase 1 (AK1) (NM_000476) Human Recombinant Protein
Sign In for Pricing
View Details 
BNC040488-100 1x 100 µL
Topoisomerase I, MT (TOP1MT/488), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details